Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation

Human Gene Therapy
D D KoeberlA D Miller

Abstract

The clotting factor VIII (FVIII) and cystic fibrosis transmembrane conductance regulator (CFTR) cDNAs have dramatically reduced levels of expression compared to clotting factor IX (FIX) and other cDNAs (100 and 1,000-fold lower, respectively), when produced in cells by using an expression vector. Part of the inhibitory signal in the FVIII cDNA has been localized to a 1.2-kb inhibitory sequence (FVIII INS), which decreased steady-state RNA levels from a retroviral vector by 30- to 100-fold. An analysis of RNA degradation indicated that the FVIII INS vector RNA is relatively stable. Nuclear run-on experiments with the FVIII INS vector demonstrated a low signal for FVIII, in contrast to the high signal for a FIX vector. The low signal for FVIII INS was not due to a decrease in transcriptional initiation. Thus, FVIII expression is reduced through a block to transcriptional elongation, as has been found in c-myc and other genes. We show that the inhibitory effect of FVIII INS is orientation dependent with regard to the promoter. In addition, the inhibitory effect is position dependent, because expression of FVIII INS sequence increased when it was moved 1 kb further from the promoter in a retroviral vector. Similar results were obse...Continue Reading

References

Jan 1, 1992·Annual Review of Medicine·R J Kaufman
May 11, 1992·Nucleic Acids Research·K WadaT Ikemura
Jun 11, 1992·Nature·A D Miller
Apr 1, 1990·Molecular and Cellular Biology·V RamamurthyR E Kellems
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T D PalmerA D Miller
May 1, 1990·Electrophoresis·R F JohnstonD L Barker
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R ReevesK R Johnson
Mar 1, 1981·Molecular and Cellular Biology·M GroudineH Weintraub
Nov 22, 1984·Nature·J GitschierR M Lawn
Nov 22, 1984·Nature·G A VeharD J Capon
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·K ZatloukalM L Birnstiel
Oct 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A KrummM Groudine

❮ Previous
Next ❯

Citations

Mar 28, 2001·The Journal of Gene Medicine·M K ChuahT VandenDriessche
Feb 11, 1998·Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·K TadaJ R Chowdhury
Jul 27, 1999·Thrombosis Research·C ChenC W Chi
Oct 30, 1998·Critical Reviews in Oncology/hematology·M K ChuahT VandenDriessche
Feb 15, 2002·British Journal of Haematology·K J Pasi
Apr 25, 2001·Clinical and Laboratory Haematology·G EmilienC Casimir
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·S Connelly, M Kaleko
Sep 25, 1999·Human Gene Therapy·R J Kaufman
Aug 31, 2002·Journal of Hematotherapy & Stem Cell Research·T TonnM Grez
Jan 20, 1996·Human Gene Therapy·S ConnellyM Kaleko
Mar 21, 1998·Human Gene Therapy·M K ChuahT VandenDriessche
Jan 1, 1997·Annual Review of Biochemistry·S M UptainM J Chamberlin
Sep 24, 2010·Journal of Biomedicine & Biotechnology·Sara Pérez-Luz, Javier Díaz-Nido
Jun 5, 2003·Expert Opinion on Biological Therapy·Assem G ZiadyMichael W Konstan
Sep 17, 2011·Journal of Thrombosis and Haemostasis : JTH·S W PipeW H Velander
Dec 9, 2003·The Journal of Biological Chemistry·Christopher B DoeringPete Lollar
Oct 23, 1997·Nature Biotechnology·R K PaleyandaH Lubon
Nov 30, 2007·Gene Therapy·P A RadcliffeK A Mitrophanous
Jul 26, 2002·The Journal of Biological Chemistry·Christopher B DoeringPete Lollar
Feb 1, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·A Van DammeT VandenDriessche
Jun 26, 2010·Expert Review of Hematology·Christopher B Doering, H Trent Spencer
Jan 22, 2017·Journal of Thrombosis and Haemostasis : JTH·S A ShestopalA G Sarafanov

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.